(Q43759284)

26 November 2017

title

The insufficient suppression of viral load by saquinavir hard gel is reversible: a retrospective cohort study (English)

1 reference

26 November 2017

1 reference

1 reference

1

Jensen-Fangel S

1 reference

26 November 2017

8

Obel N

1 reference

26 November 2017

7

Lundgren JD

1 reference

26 November 2017

2

Kirk O

1 reference

26 November 2017

Blaxhult A

3

1 reference

26 November 2017

Gerstoft J

series ordinal

4

1 reference

26 November 2017

Pedersen C

series ordinal

5

1 reference

26 November 2017

Black FT

series ordinal

6

1 reference

26 November 2017

publication date

1 March 2001

1 reference

26 November 2017

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

HIV Clinical Trials

1 reference

26 November 2017

volume

2

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

122-127

1 reference

Clinical outcome and predictive factors of failure of highly active antiretroviral therapy in antiretroviral-experienced patients in advanced stages of HIV-1 infection

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Baseline human immunodeficiency virus type 1 phenotype, genotype, and RNA response after switching from long-term hard-capsule saquinavir to indinavir or soft-gel-capsule saquinavir in AIDS clinical trials group protocol 333.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral-naive patients. NV15355 Study Team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Saquinavir Hard Gel Suppresses Viral Load Insufficiently in HIV-infected Patients Naive to Anti-retroviral Therapy: A Retrospective Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FKED4-8TW3-4ARG-HFC5

10.1310/KED4-8TW3-4ARG-HFC5

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference